ARTICLE | Company News
Cardiome, Aspen deal
January 26, 2015 8:00 AM UTC
Cardiome granted Aspen exclusive rights to commercialize Cardiome’s IV Brinavess vernakalant in South Africa. The mixed ion channel antagonist is approved in Europe and other territories for the rapi...